The U.S. Food and Drug Administration (FDA) has announced the recall of the Stryker Spine OASYS Midline Occiput Plate over a potentially dangerous side effect, signaling that there is a “reasonable possibility” that the product

As reported by Bloomberg News (10/11 Tirrell),  Reuters (10/11, Siddiqui) and  MedPage Today (10/11, Gever), the FDA issued a drug safety alert on Friday for Ariad’s cancer drug Iclusig (ponatinib) after one-fifth of patients in a postmarket

According to NBC News, the US Food and Drug Administration (FDA) announced earlier this month that a counterfeit dietary and male sexual enhancement product could be harmful to people with diabetes, high blood pressure, high cholesterol and

According to the Wall Street Journal, the U.S. Food and Drug Administration (FDA) has issued a warning in regards to recalled medical devices made by Medtronic Inc., which have been linked to injuries. The FDA issued a

According to the Associated Press, the U.S. Food and Drug Administration (FDA) is warning the public that certain cardiac defibrillators by Philips Healthcare may fail to deliver needed shock treatment during emergencies. The defibrillators are used to

The Food and Drug Administration (FDA) has issued a safety notice saying that the fungal pill Nizoral (ketoconazole) can cause severe liver injuries and adrenal gland problems and shouldn’t be used as a first-line treatment. The FDA is

The U.S. Food and Drug Administration (FDA) announced the recall recently of Nephron Pharmaceuticals’ over-the-counter bronchodilator and inhaler device due to misleading labeling and chocking concerns. The agency said that the product’s label encourages consumers

This week the FDA released a notice that a compounding pharmacy has voluntarily recalled certain human and veterinary products produced and distributed for sterile use. “Patient safety is a top priority for the agency, and giving a patient

According to the Los Angeles Times, the U.S. Food and Drug Administration’s (FDA) warning four months ago that large doses of acetaminophen could be unsafe to a patient’s liver was missed by many healthcare providers, so the

As reported by Reuters (9/26, Clarke), the U.S. Food and Drug Administration has announced that GlaxoSmithKline Plc’s chronic lymphocytic leukemia (CLL) drug, Arzerra, and Roche Holding AG and Biogen Idec Inc’s drug, Rituxan, will now contain black